Clinical trials
Phase 3 Hyperphosphatemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
| Terminated | 8 |
| Unknown status | 2 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tanabe Pharma Corporation | 9 |
| Astellas Pharma Inc | 5 |
| Bayer | 4 |
| Keryx Biopharmaceuticals | 4 |
| Kissei Pharmaceutical Co., Ltd. | 4 |
| Kyowa Kirin Co., Ltd. | 4 |
| Genzyme, a Sanofi Company | 3 |
| Alebund Pharmaceuticals | 2 |
| Ardelyx | 2 |
| Ineos Healthcare Limited | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperphosphatemia | 53 |
| Renal Insufficiency, Chronic | 28 |
| Kidney Failure, Chronic | 11 |
| Renal Insufficiency | 11 |
| Kidney Diseases | 4 |
| Anemia, Iron-Deficiency | 2 |
| Phosphorus Metabolism Disorders | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
| Disease Progression | 1 |
Trials
Showing 76 to 53 of 53. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.